Table 1.
Platelet-associated antibody detection prior to initiation with rituximab
 |
|
In the NR group, we found significantly (P = .006) more patients without detectable autoantibodies than in the response group (CR + PR + MR).
Platelet-associated antibody detection prior to initiation with rituximab
|
|
In the NR group, we found significantly (P = .006) more patients without detectable autoantibodies than in the response group (CR + PR + MR).